共 105 条
[1]
Ahlskog JE(2001)Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448-458
[2]
Muenter MD(2001)Gastric emptying time and gastric motility in patients with Parkinson’s disease Mov Disord 16 1041-1047
[3]
Hardoff R(2010)Pharmacokinetics of levodopa J Neurol 257 S253-S261
[4]
Sula M(2007)Prevalence of nonmotor symptoms in Parkinson’s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients Mov Disord 22 1623-1629
[5]
Tamir A(2012)The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life J Neurol 259 2621-2631
[6]
Contin M(2009)Intrajejunal levodopa infusion in Parkinson’s disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life Mov Disord 24 1468-1474
[7]
Martinelli P(2016)Non-motor symptoms and quality of life in patients with Parkinson’s disease in Northeastern Mexico Acta Neurol Belg 116 157-161
[8]
Martinez-Martin P(2013)Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson’s disease J Neurol Sci 332 136-140
[9]
Schapira AH(2015)Jejunal infusion of levodopa–carbidopa intestinal gel versus oral administration of levodopa–carbidopa tablets in Japanese subjects with advanced Parkinson’s disease: pharmacokinetics and pilot efficacy and safety Clin Pharmacokinet 54 975-984
[10]
Stocchi F(2014)Continuous intrajejunal infusion of levodopa–carbidopa intestinal gel for patients with advanced Parkinson’s disease: a randomised, controlled, double-blind, double-dummy study Lancet Neurol 13 141-149